SARSCOV-2 BILAN OG’RIGAN BEMORLARDA KOAGULYATSION GEMOSTAZNI SHIKASTLANISHINI LABORATORIYAVIY KO’RSATGICHLARINI BAXOLASH
Kalit so‘zlar:
SARSCoV-2, Koagulyatsion-gemostaz, D-dimer.Abstrak
Ish maqsadi: SARSCoV-2 bilan og’rigan bemorlarda koagulyatsion gemostaz ko’rsatgichlarini baxolash va ikkilamchi kasaligi bor bemorlarda giperkoagulyatsiyani rivojlanishini va SARSCoV-2 bilan og’rigan bemorlarda tomir ichi trombozi rivojlanishi haf omilarini erta laboratoriya tashxisi. Tadqiqot materiali SARSCoV-2 bilan og’rigan 80 ta bemor olindi.
References
Guo Y.R., Cao Q.D., Hong Z.S., Tan Y.Y., Chen S.D., Jin H.J., Tan K.S., Wang D.Y., Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak — an update on the status. // Mil. Med. Res. 2020; 13 (March (1)): 11.
Zhai P., Ding Y., Wu X., Long J., Zhong Y., Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int. J. Antimicrob. Agents. 2020;
Wu C., Chen X., Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020; 180 (7): 934. DOI: 10.1001/ jamainternmed.2020.0994.
Guan WJ, Ni ZY, Hu Y, et al; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18): 1708-1720.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229): 1054-1062.
Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans [published online ahead of print 27 May 2020]. Lancet Respir Med. doi:10.1016/S2213-2600(20)30243-5.
Downloads
Nashr qilingan
Nashr
Bo'lim
License
Copyright (c) 2025 Olimjonov Jahongir Tolibjon o’g’li;Djo’rabayev Tolibjon Komildjanovich

This work is licensed under a Creative Commons Attribution 4.0 International License.